Ibogaine Shows Promise Against Addiction, but Cardiac Risks Loom Large
A new review in Advances in Therapy finds that the psychedelic alkaloid ibogaine shows broad anti-addictive potential across opioid, stimulant, ...
A new review in Advances in Therapy finds that the psychedelic alkaloid ibogaine shows broad anti-addictive potential across opioid, stimulant, ...
A multi-omics study identifies ISG15-positive CD8 T cells and a CCL2-CCR2-mediated inflammatory loop as drivers of immune checkpoint inhibitor-induced myocarditis, ...
A new study in rats and cardiac cells shows that the natural naphthoquinone shikonin protects the heart from doxorubicin chemotherapy ...
A new systematic review and meta-analysis of randomized trials finds that current evidence does not confirm a consistent cardioprotective effect ...
A retrospective study of 66 cats treated with the anthracycline chemotherapy drug epirubicin found that side effects were mostly mild ...
A case report from Zhongshan Hospital describes how early second-line immunosuppression with tofacitinib and mycophenolate mofetil rescued a 77-year-old woman ...
A new case report describes a 70-year-old lung cancer patient with no cardiovascular risk factors who suffered a massive heart ...
New research shows that the immune checkpoint protein CD47 rises in doxorubicin-damaged hearts and that blocking it with an antibody ...
New research in mice shows that the nucleolar protein GNL3, produced by cardiac fibroblasts, worsens doxorubicin-induced heart injury by driving ...
Stanford researchers have published a protocol for a high-throughput stem cell-based screening platform that identifies potential antifibrotic compounds for cardiac ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine